Clinical Trial Update: Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating monthly octreotide intramuscular injections for proliferative diabetic retinopathy after laser treatment was terminated and not condu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Sandostatin (Octreotide acetate)

Snippet

Sponsor: Novartis | Conditions: Proliferative Diabetic Retinopathy | Phase 3 | Status: TERMINATED